{"id":483773,"date":"2021-04-28T16:33:44","date_gmt":"2021-04-28T20:33:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/"},"modified":"2021-04-28T16:33:44","modified_gmt":"2021-04-28T20:33:44","slug":"arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/","title":{"rendered":"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WESTLAKE VILLAGE, Calif., April  28, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ayfKsVEJg8C07EuJN8DZAcb-5LvqA3Gq171VO_atoWBfvMNUYxwiiu0IEx6Tv24zcTQxi6gB3aGOgqn539ggMduwOJJwYOT2vUMcAgGtVhw=\" rel=\"nofollow noopener\" target=\"_blank\">Arcutis Biotherapeutics, Inc.<\/a> (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a virtual fireside chat during the 2021 Truist Securities Life Sciences Summit taking place May 4-5, 2021.<\/p>\n<p align=\"justify\">Details for the presentation are as follows:<br \/> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>2021 Truist Securities Life Sciences Summit<\/strong><br \/> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Fireside Chat Date:<\/strong> Wednesday, May 5, 2021 <br \/> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Fireside Chat Time:<\/strong> 1:00 p.m. ET<\/p>\n<p align=\"justify\">The presentation will be webcast and may be accessed at the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cuDfxOIhmbnjLc4_N1hkdd6sXmnsc6M4KQ9FpqgdhVZi0KXsFHd775sDWRp98ty_neYsySDHsNHB6P2B5gmlZAk13X0TlDGI1qS1cH7XSJlY1E4ae_UUQzHu4imzuyG-rWF5FllUfMS5IHlPSkh7DdtTlNyBrkaT_o7maGLvmSxlfidpXSgoNf1pCbmN5z_a\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.arcutis.com\/events-and-presentations<\/a>. Arcutis will maintain an archived replay of the webcast on its website for 30 days after the conference.<\/p>\n<p>\n        <strong>About Arcutis &#8211; <\/strong>Bioscience, applied to the skin.<\/p>\n<p align=\"justify\">Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. Arcutis\u2019 robust <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RRXGcvY4fgobODj2gsPgcm8p6sY2KxPGVyLJWx1VqbekoQzd2fZJ3sYs8Svys4wZrHexLn8K0onY5V93Fth5Ew==\" rel=\"nofollow noopener\" target=\"_blank\">pipeline<\/a> includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company\u2019s lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cuDfxOIhmbnjLc4_N1hkdcwVdee8wunRMTZUUxjfsBeAdcfhCh7HvTi_cafQOphcsIweFpl0Yh-4wQnyKw_A95Iix4ZUQ0XGEgYvDb0V7eU=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.arcutis.com<\/a> or follow the company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RXCS0FgXp2k6BWt1lJnTY_k6EUrJ2TGOOYnlWG8epSBaaRo0A8dXh-dAWFRbIq_P1iq0dFGVdi4p6_hjA-_m8Nq3etlHR20U5xyLNXvJ9fw=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xSIAItlz9C8KrGSjOCzYZquyvWa2oijo8uoZTcMhfvAPhJnG1JdJMHKba8YlRCNHZjFKGJDhNvnoSh_8O6QzbQ==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>.<\/p>\n<p>\n        <strong>Investors and Media:<\/strong><br \/>\n        <br \/>Heather Rowe Armstrong<br \/>Vice President, Investor Relations &amp; Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_qDWHwSV-WvadVBTlYJYVm-PXMwZuX73tIgP3n0svXgEHd_QuBfjmNR3UCU4rv9CrQJF6JFgcbsUqR1Ib5biRw6wKfA5NwOE5oxWHOdBO5o=\" rel=\"nofollow noopener\" target=\"_blank\">harmstrong@arcutis.com<\/a><br \/>805-418-5006, Ext. 740<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/54e65a39-731f-4e93-b338-588b5c22f3a1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WESTLAKE VILLAGE, Calif., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a virtual fireside chat during the 2021 Truist Securities Life Sciences Summit taking place May 4-5, 2021. Details for the presentation are as follows: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02021 Truist Securities Life Sciences Summit \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat Date: Wednesday, May 5, 2021 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat Time: 1:00 p.m. ET The presentation will be webcast and may be accessed at the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at https:\/\/investors.arcutis.com\/events-and-presentations. Arcutis will maintain an archived replay of the webcast on its website for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Arcutis to Present at the 2021 Truist Securities Life Sciences Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-483773","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arcutis to Present at the 2021 Truist Securities Life Sciences Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WESTLAKE VILLAGE, Calif., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a virtual fireside chat during the 2021 Truist Securities Life Sciences Summit taking place May 4-5, 2021. Details for the presentation are as follows: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02021 Truist Securities Life Sciences Summit \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat Date: Wednesday, May 5, 2021 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat Time: 1:00 p.m. ET The presentation will be webcast and may be accessed at the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at https:\/\/investors.arcutis.com\/events-and-presentations. Arcutis will maintain an archived replay of the webcast on its website for &hellip; Continue reading &quot;Arcutis to Present at the 2021 Truist Securities Life Sciences Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T20:33:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit\",\"datePublished\":\"2021-04-28T20:33:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/\"},\"wordCount\":275,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/\",\"name\":\"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=\",\"datePublished\":\"2021-04-28T20:33:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/","og_locale":"en_US","og_type":"article","og_title":"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit - Market Newsdesk","og_description":"WESTLAKE VILLAGE, Calif., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a virtual fireside chat during the 2021 Truist Securities Life Sciences Summit taking place May 4-5, 2021. Details for the presentation are as follows: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02021 Truist Securities Life Sciences Summit \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat Date: Wednesday, May 5, 2021 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat Time: 1:00 p.m. ET The presentation will be webcast and may be accessed at the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at https:\/\/investors.arcutis.com\/events-and-presentations. Arcutis will maintain an archived replay of the webcast on its website for &hellip; Continue reading \"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-28T20:33:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit","datePublished":"2021-04-28T20:33:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/"},"wordCount":275,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/","name":"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=","datePublished":"2021-04-28T20:33:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg0MSM0MTQ1MTIxIzIxOTQwNTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-present-at-the-2021-truist-securities-life-sciences-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Arcutis to Present at the 2021 Truist Securities Life Sciences Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=483773"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483773\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=483773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=483773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=483773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}